Tuesday, November 03, 2015 7:48:33 PM
1.2 Million, The Principal Amount of the Debenture accrues interest at the rate of 5% per annum. Under the terms of the Purchase Agreement and Debenture, $2,800,000 of the Investment Amount will deposited into a deposit control account and such amount will remain in the deposit control account pending the achievement of certain milestones by the Company and the satisfaction of certain equity conditions set forth in the Debenture.
For an infant biotech, these terms are outstanding! The 5% interest rate on the initial 1.2 Millioin is very reasonable, and the additional dollars are dependent upon milestone achievement. This is not a open credit card issuance! Accountability and discipline! Looks very good. PPCH is getting ready for a serious move which may begin tomorrow. We'll see how the market likes this, but it looks very good!
Recent PPCB News
- Biopharma on a Tear After Certificate of Grant from Japanese Patent Office • AllPennyStocks.com • 06/25/2024 04:26:00 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM